DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Renvela (Sevelamer) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Renvela (Sevelamer) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Renvela side effects in

Reported by a consumer/non-health professional from Argentina on 2012-05-14

Patient:

Reactions: Ligament Rupture, Tendon Rupture, Condition Aggravated, Fall, Muscle Rupture, Malaise, Fatigue, Asthenia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Hectorol
    Dosage: 7.5 mg, 3x/w
    Administration route: Oral
    Indication: Hyperparathyroidism Secondary
    Start date: 2011-09-01
    End date: 2011-10-01

Renvela
    Dosage: 1.6 g, 3x/w
    Administration route: Oral
    Indication: Hyperphosphataemia
    Start date: 2011-09-01
    End date: 2011-10-01

Other drugs received by patient: Carvedilol; Alprazolam; Enalapril Maleate



Possible Renvela side effects in

Reported by a consumer/non-health professional from Argentina on 2012-04-27

Patient:

Reactions: Ligament Rupture, Tendon Rupture, Condition Aggravated, Fall, Muscle Rupture, Fatigue, Malaise, Asthenia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Renvela
    Dosage: 1.6 g, 3x/w
    Administration route: Oral
    Indication: Hyperphosphataemia
    Start date: 2011-09-01
    End date: 2011-10-01

Hectorol
    Dosage: 7.5 mg, 3x/w
    Administration route: Oral
    Indication: Hyperparathyroidism Secondary
    Start date: 2011-09-01
    End date: 2011-10-01

Other drugs received by patient: Enalapril Maleate; Carvedilol; Alprazolam



Possible Renvela side effects in

Reported by a physician from Argentina on 2012-03-21

Patient:

Reactions: Pain, Condition Aggravated, Fall, Muscle Rupture, Fatigue, Malaise, Bone Disorder, Gait Disturbance, Muscle Disorder, Asthenia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Renvela
    Dosage: unk
    Administration route: Oral
    Indication: Hyperphosphataemia
    Start date: 2010-01-01
    End date: 2011-10-01

Hectorol
    Dosage: unk
    Administration route: Oral
    Indication: Hyperparathyroidism Secondary
    Start date: 2010-01-01
    End date: 2011-10-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017